Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 4/2018

Open Access 01-05-2018

Prothrombotic factors do not increase the risk of recurrent ischemic events after cryptogenic stroke at young age: the FUTURE study

Authors: Mijntje M. I. Schellekens, Mayte E. van Alebeek, Renate M. Arntz, Nathalie E. Synhaeve, Noortje A. M. M. Maaijwee, Hennie C. Schoonderwaldt, Maureen J. van der Vlugt, Ewoud J. van Dijk, Loes C. A. Rutten-Jacobs, Frank-Erik de Leeuw

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2018

Login to get access

Abstract

Background

The role of hypercoagulable states and preceding infections in the etiology of young stroke and their role in developing recurrent ischemic events remains unclear. Our aim is to determine the prevalence of these conditions in patients with cryptogenic stroke at young age and to assess the long-term risk of recurrent ischemic events in patients with and without a hypercoagulable state or a recent pre-stroke infection with Borrelia or Syphilis.

Patients and methods

We prospectively included patients with a first-ever transient ischemic attack or ischemic stroke, aged 18–50, admitted to our hospital between 1995 and 2010. A retrospective analysis was conducted of prothrombotic factors and preceding infections. Outcome was recurrent ischemic events.

Results

Prevalence of prothrombotic factors did not significantly differ between patients with a cryptogenic stroke and with an identified cause (24/120 (20.0%) and 32/174 (18.4%) respectively). In patients with a cryptogenic stroke the long-term risk [mean follow-up of 8.9 years (SD 4.6)] of any recurrent ischemic event or recurrent cerebral ischemia did not significantly differ between patients with and without a hypercoagulable state or a recent infection. In patients with a cryptogenic stroke 15-years cumulative risk of any recurrent ischemic event was 24 and 23% in patients with and without any prothrombotic factor respectively.

Conclusions

The prevalence of prothrombotic factors and preceding infections did not significantly differ between stroke patients with a cryptogenic versus an identified cause of stroke and neither is significantly associated with an increased risk of recurrent ischemic events after cryptogenic stroke.
Appendix
Available only for authorised users
Literature
10.
go back to reference Pezzini A, Grassi M, Lodigiani C, Patella R, Gandolfo C, Zini A, Delodovici ML, Paciaroni M, Del Sette M, Toriello A, Musolino R, Calabro RS, Bovi P, Adami A, Silvestrelli G, Sessa M, Cavallini A, Marcheselli S, Bonifati DM, Checcarelli N, Tancredi L, Chiti A, Del Zotto E, Spalloni A, Giossi A, Volonghi I, Costa P, Giacalone G, Ferrazzi P, Poli L, Morotti A, Rasura M, Simone AM, Gamba M, Cerrato P, Micieli G, Melis M, Massucco D, De Giuli V, Iacoviello L, Padovani A (2014) Predictors of long-term recurrent vascular events after ischemic stroke at young age: the Italian Project on Stroke in Young Adults. Circulation 129(16):1668–1676. https://doi.org/10.1161/circulationaha.113.005663 CrossRefPubMed Pezzini A, Grassi M, Lodigiani C, Patella R, Gandolfo C, Zini A, Delodovici ML, Paciaroni M, Del Sette M, Toriello A, Musolino R, Calabro RS, Bovi P, Adami A, Silvestrelli G, Sessa M, Cavallini A, Marcheselli S, Bonifati DM, Checcarelli N, Tancredi L, Chiti A, Del Zotto E, Spalloni A, Giossi A, Volonghi I, Costa P, Giacalone G, Ferrazzi P, Poli L, Morotti A, Rasura M, Simone AM, Gamba M, Cerrato P, Micieli G, Melis M, Massucco D, De Giuli V, Iacoviello L, Padovani A (2014) Predictors of long-term recurrent vascular events after ischemic stroke at young age: the Italian Project on Stroke in Young Adults. Circulation 129(16):1668–1676. https://​doi.​org/​10.​1161/​circulationaha.​113.​005663 CrossRefPubMed
12.
go back to reference Munts AG, van Genderen PJ, Dippel DW, van Kooten F, Koudstaal PJ (1998) Coagulation disorders in young adults with acute cerebral ischaemia. J Neurol 245(1):21–25CrossRefPubMed Munts AG, van Genderen PJ, Dippel DW, van Kooten F, Koudstaal PJ (1998) Coagulation disorders in young adults with acute cerebral ischaemia. J Neurol 245(1):21–25CrossRefPubMed
14.
go back to reference Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D (1992) Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke 23(2):189–193CrossRefPubMed Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D (1992) Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke 23(2):189–193CrossRefPubMed
15.
go back to reference Rutten-Jacobs LC, Maaijwee NA, Arntz RM, Van Alebeek ME, Schaapsmeerders P, Schoonderwaldt HC, Dorresteijn LD, Overeem S, Drost G, Janssen MC, van Heerde WL, Kessels RP, Zwiers MP, Norris DG, van der Vlugt MJ, van Dijk EJ, de Leeuw FE (2011) Risk factors and prognosis of young stroke. The FUTURE study: a prospective cohort study. Study rationale and protocol. BMC Neurol 11:109. https://doi.org/10.1186/1471-2377-11-109 CrossRefPubMedPubMedCentral Rutten-Jacobs LC, Maaijwee NA, Arntz RM, Van Alebeek ME, Schaapsmeerders P, Schoonderwaldt HC, Dorresteijn LD, Overeem S, Drost G, Janssen MC, van Heerde WL, Kessels RP, Zwiers MP, Norris DG, van der Vlugt MJ, van Dijk EJ, de Leeuw FE (2011) Risk factors and prognosis of young stroke. The FUTURE study: a prospective cohort study. Study rationale and protocol. BMC Neurol 11:109. https://​doi.​org/​10.​1186/​1471-2377-11-109 CrossRefPubMedPubMedCentral
17.
go back to reference Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T (1980) Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 58(1):113–130PubMedPubMedCentral Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T (1980) Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 58(1):113–130PubMedPubMedCentral
18.
go back to reference Hatano S (1976) Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54(5):541–553PubMedPubMedCentral Hatano S (1976) Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54(5):541–553PubMedPubMedCentral
19.
go back to reference Arntz RM, van Alebeek ME, Synhaeve NE, van Pamelen J, Maaijwee NA, Schoonderwaldt H, van der Vlugt MJ, van Dijk EJ, Rutten-Jacobs LC, de Leeuw F-E (2016) The very long-term risk and predictors of recurrent ischaemic events after a stroke at a young age: The FUTURE study. Eur Stroke J 1(4):337–345. https://doi.org/10.1177/2396987316673440 CrossRef Arntz RM, van Alebeek ME, Synhaeve NE, van Pamelen J, Maaijwee NA, Schoonderwaldt H, van der Vlugt MJ, van Dijk EJ, Rutten-Jacobs LC, de Leeuw F-E (2016) The very long-term risk and predictors of recurrent ischaemic events after a stroke at a young age: The FUTURE study. Eur Stroke J 1(4):337–345. https://​doi.​org/​10.​1177/​2396987316673440​ CrossRef
20.
go back to reference Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici MG, Mattle HP, Rothwell PM (2009) Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Cerebrovasc Dis 27(5):509–518. https://doi.org/10.1159/000212671 CrossRefPubMed Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici MG, Mattle HP, Rothwell PM (2009) Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Cerebrovasc Dis 27(5):509–518. https://​doi.​org/​10.​1159/​000212671 CrossRefPubMed
21.
go back to reference Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20(7):864–870CrossRefPubMed Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20(7):864–870CrossRefPubMed
22.
go back to reference Kasner SE, Chalela JA, Luciano JM, Cucchiara BL, Raps EC, McGarvey ML, Conroy MB, Localio AR (1999) Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke 30(8):1534–1537CrossRefPubMed Kasner SE, Chalela JA, Luciano JM, Cucchiara BL, Raps EC, McGarvey ML, Conroy MB, Localio AR (1999) Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke 30(8):1534–1537CrossRefPubMed
23.
go back to reference Williams LS, Yilmaz EY, Lopez-Yunez AM (2000) Retrospective assessment of initial stroke severity with the NIH Stroke Scale. Stroke 31(4):858–862CrossRefPubMed Williams LS, Yilmaz EY, Lopez-Yunez AM (2000) Retrospective assessment of initial stroke severity with the NIH Stroke Scale. Stroke 31(4):858–862CrossRefPubMed
24.
go back to reference Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 (1):35–41CrossRefPubMed Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 (1):35–41CrossRefPubMed
26.
go back to reference Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernandez-Aviles F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N (2007) Universal definition of myocardial infarction. Circulation 116(22):2634–2653. https://doi.org/10.1161/circulationaha.107.187397 CrossRefPubMed Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernandez-Aviles F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N (2007) Universal definition of myocardial infarction. Circulation 116(22):2634–2653. https://​doi.​org/​10.​1161/​circulationaha.​107.​187397 CrossRefPubMed
Metadata
Title
Prothrombotic factors do not increase the risk of recurrent ischemic events after cryptogenic stroke at young age: the FUTURE study
Authors
Mijntje M. I. Schellekens
Mayte E. van Alebeek
Renate M. Arntz
Nathalie E. Synhaeve
Noortje A. M. M. Maaijwee
Hennie C. Schoonderwaldt
Maureen J. van der Vlugt
Ewoud J. van Dijk
Loes C. A. Rutten-Jacobs
Frank-Erik de Leeuw
Publication date
01-05-2018
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 4/2018
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-1631-4

Other articles of this Issue 4/2018

Journal of Thrombosis and Thrombolysis 4/2018 Go to the issue